Epitalon Acetate CAS:307297-40-1

Epithalon was first discovered in the late 1980's by Prof. Vladimir Khavinson from St. Petersburg, Russia. It has been studied extensively ever since. It is known by several names, including Epitalon, Epitalon, Epithalone, Epithalamin and Epithalamine. Since all the patents are held by the Russian inventor there is not much interest for this tetra-peptide from the western big pharma industry. This makes the substance fairly unknown in the west due to the absence of marketing usually seen with big pharma products. In Russia it is currently in clinical studies and shows prospective results as treatment for liver disorders, neuropathology, psychiatry and geriatrics.

Epitalon verminder die ouderdomverwante veranderinge in immuun- en neuro-endokriene stelsels, verminder die voorkoms van herhalende infeksies en chroniese siektes. Langtermyn kliniese proewe het getoon dat epitalamien wanbalans in prooksidasie- en antioksidasiestelsels by pasiënte met ouderdomverwante patologie uitskakel.. Resultate van 12-maande behandeling met Epithalon by pasiënte met tekens van versnelde veroudering het normaliserende effek op metabolisme en toestand van verskeie funksionele stelsels getoon. Verhoogde uriensuur, alkaliese fosfatase en cholesterol by ouer pasiënte het na normaal teruggekeer 10 dae van behandeling, en het in 'n paar maande daarna stabiel gebly.